Involvement of c-abl in the radiation-induced inhibition of myoblast differentiation

International Journal of Radiation Biology

Volumn 80, Issue 10, 2004, Pages 729-736

  Hoerth, E ^b   Kodym, R ^a  

^a Clin for Radiother and Radiobiol   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; BIOCHEMICAL MARKER; IMATINIB; MYOGENIN; MYOSIN HEAVY CHAIN; PHOSPHOTRANSFERASE INHIBITOR; TRANSCRIPTION FACTOR; TYROSINE KINASE RECEPTOR; ENZYME INHIBITOR; MYOG PROTEIN, MOUSE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL DIFFERENTIATION; CELL TYPE; ENZYME ASSAY; GENETIC TRANSFECTION; IONIZING RADIATION; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; UPREGULATION; ANIMAL; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; GENE EXPRESSION; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; TIME;

ANIMALIA; IKEDA; MURINAE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; ENZYME INHIBITORS; GENE EXPRESSION; MICE; MUTATION; MYOBLASTS; MYOGENIN; MYOSIN HEAVY CHAINS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-ABL; TIME FACTORS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 12344293915     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/09553000400017408     Document Type: Article

References (20)

1. BENNETT, R. L. and HOFFMANN, F. M., 1992, Increased levels of the Drosophila Abelson tyrosine kinase in nerves and muscles: subcellular localization and mutant phenotypes imply a role in cell-cell interactions. Development, 116, 953-966.
2. BRUSTIS, J. J., ELAMRANI, N., BALCERZAK, D., SAFWATE, A., SORIANO, M., POUSSARD, S., COTTIN, P. and DUCASTAING, A., 1994, Rat myoblast fusion requires exteriorized m-calpain activity. European Journal of Cell Biology, 64, 320-327.
3. BUCHDUNGER, E., CIOFFI, C. L., LAW, N., STOVER, D., OHNO-JONES, S., DRUCKER, B. J. and LYDON, N. B., 2000, Abl protein-tyrosine kinase inhibitor STI 571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. The Journal of Pharmacology And Experimental Therapeutics, 295, 139-145.
4. CONSTANTIN, B., IMBERT, N., BESSE, D., COGNARD, C. A. and RAYMOND, G., 1995, Cultured rat skeletal muscle cells treated with cytochalasin exhibit normal dystrophin expression and intracellular free calcium control. Biology of the Cell, 85, 125-135.
5. DRUKER, B. J., TAMURA, S., BUCHDUNGER, E., OHNO, S., SEGAL, G. M., FANNING, S., ZIMMERMANN, J. and LYDON, N. B., 1996, Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Medicine, 2, 561-566.
6. HERSKIND, C., BENTZEN, S. M., OVERGAARD, J., OVERGAARD, M., BAMBERG, M. and RODEMANN, H. P., 1998, Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy. Radiotherapy and Oncology, 47(3), 263-269.
7. IKEDA, S., HACHISU, R., YAMAGUCHI, A., GAO, Y. H. and OKANO, T., 2000, Radiation retards muscle differentiation but does not affect osteoblastic differentiation induced by bone morphogenetic protein-2 in C2C12 myoblasts. International Journal of Radiation Biology, 76, 403-411.
8. KHARBANDA, S., REN, F., PANDEY, P., SHAFMAN, T. D., FELLER, S. M., WEICHSELBAUM, R. R. and KUFE, D. W., 1995, Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature, 376, 785-788.
9. KHARBANDA, S., PANDEY, P., JIN, S., INOUE, S., BHARTI, A., YUAN, Z.-M., WEICHSELBAUM, R., WEAVER, D. and KUFE, D., 1997. Functional interaction between DNA-PK and c-Abl in response to DNA damage. Nature, 386, 732-735.
10. KHARBANDA, S., YUAN, Z.-M., WEICHSELBAUM, R. and KUFE, D., 1998. Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene, 17, 3309-3318.
11. O'NEILL, A. J., COTTER, T. G., RUSSELL, J. M. and GAFFNEY, E. F., 1997, Abl expression in human fetal and adult tissues, tumours, and tumour microvessels. The Journal of Pathology, 183, 325-329.
12. PURI, P. L., BHAKTA, K., WOOD, L. D., COSTANZO, A., ZHU, J. and WANG, J. Y., 2002, A myogenic differentiation checkpoint activated by genotoxic stress. Nature Genetics, 32(4), 585-593.
13. RODEMANN, H. P., BINDER, A., BURGER, A., GUVEN, N., LOFFLER, H. and BAMBERG, M., 1996, The underlying cellular mechanism of fibrosis. Kidney International, Supplement 54, S32-36.
14. SAMBROOK, J., FRITSCH, E. F. and MANIATIS, T., 1989, Molecular Cloning: A laboratory manual, 2nd edn (New York: Cold Spring Harbor).
15. SAWYERS, C. L., MCLAUGHLIN, J., GOGA, A., HAVLIK, M. and WITTE, O., 1994, The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell, 77, 121-131.
16. TELFORD, J., BURCKHARDT, J., BUTLER, B. and PIRROTA, V., 1985, Alternative processing and development control of the transcripts of the Drosophila abl oncogene homologue. EMBO Journal, 4, 2609-2615.
17. VAN ETTEN, F. A., 1999, Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends in Cell Biology, 9, 179-186.
18. WANG, J. Y. J., 2000, Regulation of cell death by the Abl tyrosine kinase. Oncogene, 19, 5643-5650.
19. YUAN, Z.-M., HUANG, Y., WHANG, Y., SAWYERS, C., WEICHSELBAUM, R., KHARBANDA, S. and KUFE, D., 1996, Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature, 382, 272-274.
20. YUAN, Z.-M., HUANG, Y., ISHIKO, T., KHARBANDA, S. and WEICHSELBAUM, R., 1997, Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proceedings of the National Academy of Sciences of the United States of America, 94, 1437-1440.